Article Versions Notes

Kotani Y, Imura Y, Nakai S, Chijimatsu R, Takami H, Inoue A, Mae H, Takenaka S, Outani H, Okada S. Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells. Cancers. 2024; 16(6):1125. https://doi.org/10.3390/cancers16061125

Kotani, Yuki, Yoshinori Imura, Sho Nakai, Ryota Chijimatsu, Haruna Takami, Akitomo Inoue, Hirokazu Mae, Satoshi Takenaka, Hidetatsu Outani, and Seiji Okada. 2024. "Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells" Cancers 16, no. 6: 1125. https://doi.org/10.3390/cancers16061125

Kotani, Y., Imura, Y., Nakai, S., Chijimatsu, R., Takami, H., Inoue, A., Mae, H., Takenaka, S., Outani, H., & Okada, S. (2024). Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells. Cancers, 16(6), 1125. https://doi.org/10.3390/cancers16061125